US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

1.68

+0.14009.09%

Volume:1.54M

Turnover:2.59M

Market Cap:55.43M

PE:-2.78

High:1.75

Open:1.68

Low:1.62

Close:1.54

52wk High:3.74

52wk Low:1.40

Shares:32.99M

Float Shares:28.34M

Volume Ratio:36.18

T/O Rate:5.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6046

EPS(LYR):-1.0476

ROE:-459.53%

ROA:-107.22%

PB:14.30

PE(LYR):-1.60

Loading ...

Overview Company News Filings

MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells

MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy

MAIA Biotechnology Q2 EPS $(0.18) Beats $(0.24) Estimate

FDA Grants Fast Track Designation to MAIA Biotechnology's Ateganosine for Non-Small Cell Lung Cancer Treatment

Maia Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer

THOMSON REUTERS

MAIA Biotechnology Publishes Promising Preclinical Cancer Data

MAIA Biotechnology announces publication of ateganosine prodrug data

MAIA Biotechnology Inc. Advances Cancer Treatment with New Clinical Study on Promising Ateganosine Prodrugs

MAIA Biotechnology Begins Phase 2 Trial Expansion

MAIA Biotechnology doses first patient in Taiwan in THIO-101 trial

Maia Biotechnology Inc. Expands Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer with First Patient Dosed in Taiwan

MAIA Biotechnology Unveils Promising Telomere-Targeting Agents for Cancer at Upcoming FEBS 2025 Congress

Maia Biotechnology Signs Stock Purchase Agreement with Prevail Partners for Phase 3 Cancer Study Funding

MAIA Biotechnology Appoints Oncologists to Advisory Board

BRIEF-MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board

MAIA Biotechnology Inc. Appoints Leading Oncologists Claudia Fulgenzi and David Pinato to Scientific Advisory Board for Upcoming HCC Clinical Trials

Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live

Maia Biotechnology Inc. Announces New Clinical Study Agreement with Roche for Cancer Treatment Combination

MAIA Biotechnology Enters Inducement Offer Agreements

Maia Biotechnology Inc. Announces Warrant Exercise Agreements for 219,283 Shares at Reduced Price of $1.50, Securing $328,925 in Gross Proceeds

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MAIA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":1.68,"timestamp":1756312957190,"preClose":1.54,"halted":0,"volume":1537000,"delay":0,"floatShares":28340000,"shares":32993220,"eps":-0.604589,"marketStatus":"Trading","change":0.14,"latestTime":"08-27 12:43:13 EDT","open":1.68,"high":1.75,"low":1.62,"amount":2589752.9337,"amplitude":0.084416,"askPrice":1.68,"askSize":100,"bidPrice":1.66,"bidSize":118,"shortable":3,"etf":0,"ttmEps":-0.604589,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756324800000},"marketStatusCode":2,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":1.54,"preHourTrading":{"tag":"盘前","latestPrice":1.66,"preClose":1.54,"latestTime":"09:29 EDT","volume":115756,"amount":192138.3027116,"timestamp":1756301393731},"postHourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.54,"latestTime":"19:58 EDT","volume":9156,"amount":14554.6846,"timestamp":1756252727882},"volumeRatio":36.181791},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","floatShares":28340000,"roa":"-107.22%","roe":"-459.53%","lyrEps":-1.047624,"volumeRatio":36.181791,"shares":32993220,"dividePrice":0,"high":1.75,"amplitude":0.084416,"preClose":1.54,"low":1.62,"week52Low":1.4,"pbRate":"14.30","week52High":3.742,"institutionHeld":0,"latestPrice":1.68,"committee":0.082569,"eps":-0.604589,"divideRate":0,"volume":1537000,"delay":0,"ttmEps":-0.604589,"open":1.68,"prevYearClose":1.98,"prevWeekClose":1.58,"prevMonthClose":1.57,"prevQuarterClose":1.8,"fiveDayClose":1.58,"twentyDayClose":1.61,"sixtyDayClose":1.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAIA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-11","symbol":"MAIA","fiscalQuarterEnding":"2025/06","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAIA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1677038400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAIA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAIA","date":"2025-08-26","current":-3.223399,"percent":0.093458,"low":-5.555213,"twenty":-2.835718,"median":-2.32296,"eighty":-1.715028,"high":-0.77644,"avg":-2.291657,"sd":0.699546,"marketCap":52129287},"quantilePoints":[{"date":"2022-07-29","current":-4.130799,"twenty":-3.74477,"median":-3.33193,"eighty":-3.032982,"marketCap":61688243},{"date":"2022-08-05","current":-3.418592,"twenty":-4.327368,"median":-3.717719,"eighty":-3.321732,"marketCap":51052339},{"date":"2022-08-12","current":-3.539667,"twenty":-3.942776,"median":-3.513542,"eighty":-3.113768,"marketCap":52860442},{"date":"2022-08-19","current":-2.813217,"twenty":-3.757603,"median":-3.418592,"eighty":-3.057447,"marketCap":42011820},{"date":"2022-08-26","current":-2.813564,"twenty":-3.645074,"median":-3.16932,"eighty":-3.031815,"marketCap":41665794},{"date":"2022-09-02","current":-3.160645,"twenty":-3.562458,"median":-3.149236,"eighty":-2.973073,"marketCap":46805669},{"date":"2022-09-09","current":-3.035105,"twenty":-3.531121,"median":-3.079413,"eighty":-2.987843,"marketCap":44946565},{"date":"2022-09-16","current":-2.628947,"twenty":-3.505948,"median":-3.054305,"eighty":-2.874118,"marketCap":38931818},{"date":"2022-09-23","current":-2.400022,"twenty":-3.459888,"median":-3.035105,"eighty":-2.808995,"marketCap":35541688},{"date":"2022-09-30","current":-2.436946,"twenty":-3.337714,"median":-3.018069,"eighty":-2.628947,"marketCap":36088483},{"date":"2022-10-07","current":-2.481254,"twenty":-3.200415,"median":-2.976027,"eighty":-2.544762,"marketCap":36744637},{"date":"2022-10-14","current":-2.429561,"twenty":-3.170744,"median":-2.946489,"eighty":-2.506362,"marketCap":35979124},{"date":"2022-10-21","current":-2.326175,"twenty":-3.161577,"median":-2.817793,"eighty":-2.443001,"marketCap":34448097},{"date":"2022-10-28","current":-2.392637,"twenty":-3.156081,"median":-2.809698,"eighty":-2.436946,"marketCap":35432328},{"date":"2022-11-04","current":-2.673255,"twenty":-3.130168,"median":-2.80618,"eighty":-2.436946,"marketCap":39587972},{"date":"2022-11-11","current":-2.861595,"twenty":-3.092705,"median":-2.80618,"eighty":-2.443001,"marketCap":41539705},{"date":"2022-11-18","current":-2.59391,"twenty":-3.074979,"median":-2.80618,"eighty":-2.45489,"marketCap":37653909},{"date":"2022-11-25","current":-2.639153,"twenty":-3.06641,"median":-2.741401,"eighty":-2.463531,"marketCap":38310664},{"date":"2022-12-02","current":-2.782421,"twenty":-3.056964,"median":-2.74683,"eighty":-2.481254,"marketCap":40390385},{"date":"2022-12-09","current":-2.639153,"twenty":-3.048124,"median":-2.714557,"eighty":-2.485685,"marketCap":38310664},{"date":"2022-12-16","current":-2.571289,"twenty":-3.039919,"median":-2.704828,"eighty":-2.491357,"marketCap":37325532},{"date":"2022-12-23","current":-2.526046,"twenty":-3.035105,"median":-2.684395,"eighty":-2.489852,"marketCap":36668778},{"date":"2022-12-30","current":-2.646693,"twenty":-3.035105,"median":-2.669314,"eighty":-2.488344,"marketCap":38420123},{"date":"2023-01-06","current":-2.646693,"twenty":-3.028524,"median":-2.669314,"eighty":-2.494376,"marketCap":38420123},{"date":"2023-01-13","current":-3.008634,"twenty":-3.036309,"median":-2.678825,"eighty":-2.495884,"marketCap":43674156},{"date":"2023-01-20","current":-3.649345,"twenty":-3.053419,"median":-2.693672,"eighty":-2.500398,"marketCap":52974891},{"date":"2023-01-27","current":-3.381885,"twenty":-3.088275,"median":-2.710179,"eighty":-2.507838,"marketCap":49092379},{"date":"2023-02-03","current":-3.566626,"twenty":-3.137263,"median":-2.727137,"eighty":-2.510896,"marketCap":51774125},{"date":"2023-02-10","current":-3.332873,"twenty":-3.167896,"median":-2.752259,"eighty":-2.519723,"marketCap":48380895},{"date":"2023-02-17","current":-3.415817,"twenty":-3.245403,"median":-2.79807,"eighty":-2.525852,"marketCap":49584945},{"date":"2023-02-24","current":-3.566626,"twenty":-3.3193,"median":-2.80618,"eighty":-2.527554,"marketCap":51774125},{"date":"2023-03-03","current":-3.4686,"twenty":-3.350216,"median":-2.813564,"eighty":-2.531068,"marketCap":50351158},{"date":"2023-03-10","current":-3.016174,"twenty":-3.350216,"median":-2.827663,"eighty":-2.542251,"marketCap":43783616},{"date":"2023-03-17","current":-2.473263,"twenty":-3.346445,"median":-2.827663,"eighty":-2.542251,"marketCap":35902565},{"date":"2023-03-24","current":-2.399976,"twenty":-3.342675,"median":-2.81339,"eighty":-2.516804,"marketCap":38927270},{"date":"2023-03-31","current":-2.345739,"twenty":-3.337397,"median":-2.80618,"eighty":-2.495884,"marketCap":38047557},{"date":"2023-04-06","current":-2.284723,"twenty":-3.326087,"median":-2.805042,"eighty":-2.481254,"marketCap":37057881},{"date":"2023-04-14","current":-2.447433,"twenty":-3.292155,"median":-2.76734,"eighty":-2.461933,"marketCap":39697018},{"date":"2023-04-21","current":-2.393197,"twenty":-3.261993,"median":-2.739718,"eighty":-2.455007,"marketCap":38817306},{"date":"2023-04-28","current":-1.958672,"twenty":-3.24842,"median":-2.712368,"eighty":-2.44201,"marketCap":31769373},{"date":"2023-05-05","current":-2.318612,"twenty":-3.242387,"median":-2.695409,"eighty":-2.436946,"marketCap":37607553},{"date":"2023-05-12","current":-2.109365,"twenty":-3.242387,"median":-2.678825,"eighty":-2.414792,"marketCap":34746108},{"date":"2023-05-19","current":-1.988788,"twenty":-3.237189,"median":-2.669314,"eighty":-2.399985,"marketCap":33656034},{"date":"2023-05-26","current":-1.827752,"twenty":-3.208406,"median":-2.654233,"eighty":-2.392749,"marketCap":30930849},{"date":"2023-06-02","current":-2.069306,"twenty":-3.176442,"median":-2.646693,"eighty":-2.379637,"marketCap":35018627},{"date":"2023-06-09","current":-1.988788,"twenty":-3.162198,"median":-2.639153,"eighty":-2.33896,"marketCap":33656034},{"date":"2023-06-16","current":-1.851908,"twenty":-3.160645,"median":-2.635382,"eighty":-2.318791,"marketCap":31339627},{"date":"2023-06-23","current":-1.763338,"twenty":-3.153651,"median":-2.628947,"eighty":-2.307373,"marketCap":29840775},{"date":"2023-06-30","current":-1.731131,"twenty":-3.150302,"median":-2.609948,"eighty":-2.28744,"marketCap":29295738},{"date":"2023-07-07","current":-1.779442,"twenty":-3.141254,"median":-2.59768,"eighty":-2.242232,"marketCap":30113294},{"date":"2023-07-14","current":-1.755286,"twenty":-3.123249,"median":-2.586369,"eighty":-2.20532,"marketCap":29704516},{"date":"2023-07-21","current":-1.851908,"twenty":-3.111184,"median":-2.578041,"eighty":-2.067676,"marketCap":31339627},{"date":"2023-07-28","current":-1.859959,"twenty":-3.104623,"median":-2.56987,"eighty":-2.008112,"marketCap":31475886},{"date":"2023-08-04","current":-1.715028,"twenty":-3.097572,"median":-2.563748,"eighty":-1.974295,"marketCap":29023220},{"date":"2023-08-11","current":-1.557401,"twenty":-3.086713,"median":-2.556208,"eighty":-1.943698,"marketCap":28252239},{"date":"2023-08-18","current":-1.369309,"twenty":-3.075231,"median":-2.531381,"eighty":-1.90827,"marketCap":24840133},{"date":"2023-08-25","current":-1.437022,"twenty":-3.068706,"median":-2.525562,"eighty":-1.887815,"marketCap":26068491},{"date":"2023-09-01","current":-1.316644,"twenty":-3.064492,"median":-2.5071,"eighty":-1.866401,"marketCap":23884743},{"date":"2023-09-08","current":-1.32732,"twenty":-3.056964,"median":-2.495884,"eighty":-1.852819,"marketCap":24078428},{"date":"2023-09-15","current":-1.319779,"twenty":-3.048124,"median":-2.488344,"eighty":-1.851908,"marketCap":23941618},{"date":"2023-09-22","current":-1.161405,"twenty":-3.039919,"median":-2.477259,"eighty":-1.830989,"marketCap":21068624},{"date":"2023-09-29","current":-1.357487,"twenty":-3.035105,"median":-2.458182,"eighty":-1.797155,"marketCap":24625665},{"date":"2023-10-06","current":-1.89294,"twenty":-3.03346,"median":-2.451363,"eighty":-1.795545,"marketCap":34339121},{"date":"2023-10-13","current":-1.696859,"twenty":-3.026246,"median":-2.440654,"eighty":-1.781052,"marketCap":30782081},{"date":"2023-10-20","current":-1.772274,"twenty":-3.023715,"median":-2.436946,"eighty":-1.772274,"marketCap":32150173},{"date":"2023-10-27","current":-1.402736,"twenty":-3.020699,"median":-2.436946,"eighty":-1.772274,"marketCap":25446520},{"date":"2023-11-03","current":-1.538485,"twenty":-3.016174,"median":-2.424938,"eighty":-1.763338,"marketCap":27909087},{"date":"2023-11-10","current":-1.563529,"twenty":-3.013408,"median":-2.414792,"eighty":-1.758507,"marketCap":28319514},{"date":"2023-11-17","current":-1.098625,"twenty":-3.009008,"median":-2.400022,"eighty":-1.737573,"marketCap":19898915},{"date":"2023-11-24","current":-1.0945,"twenty":-3.00802,"median":-2.398918,"eighty":-1.715028,"marketCap":19824192},{"date":"2023-12-01","current":-0.93547,"twenty":-3.003917,"median":-2.393197,"eighty":-1.697272,"marketCap":16943754},{"date":"2023-12-08","current":-0.853009,"twenty":-2.993064,"median":-2.385536,"eighty":-1.662077,"marketCap":15450179},{"date":"2023-12-15","current":-0.830323,"twenty":-2.97455,"median":-2.366078,"eighty":-1.603306,"marketCap":15039276},{"date":"2023-12-22","current":-0.963534,"twenty":-2.967166,"median":-2.34235,"eighty":-1.566156,"marketCap":17452066},{"date":"2023-12-29","current":-1.159983,"twenty":-2.962735,"median":-2.332248,"eighty":-1.560368,"marketCap":21010254},{"date":"2024-01-05","current":-1.113209,"twenty":-2.959095,"median":-2.329178,"eighty":-1.540033,"marketCap":20163067},{"date":"2024-01-12","current":-1.319013,"twenty":-2.946198,"median":-2.318612,"eighty":-1.505189,"marketCap":23890693},{"date":"2024-01-19","current":-1.178692,"twenty":-2.917694,"median":-2.307373,"eighty":-1.461419,"marketCap":21349130},{"date":"2024-01-26","current":-1.262884,"twenty":-2.860841,"median":-2.292944,"eighty":-1.43018,"marketCap":22874067},{"date":"2024-02-02","current":-1.449978,"twenty":-2.853404,"median":-2.250825,"eighty":-1.422652,"marketCap":26262818},{"date":"2024-02-09","current":-1.337722,"twenty":-2.835718,"median":-2.238161,"eighty":-1.406928,"marketCap":24229568},{"date":"2024-02-16","current":-1.472372,"twenty":-2.835615,"median":-2.225173,"eighty":-1.406928,"marketCap":26668418},{"date":"2024-02-23","current":-1.37859,"twenty":-2.835204,"median":-2.173979,"eighty":-1.403205,"marketCap":24969793},{"date":"2024-03-01","current":-1.228539,"twenty":-2.828334,"median":-2.067947,"eighty":-1.384495,"marketCap":22251992},{"date":"2024-03-08","current":-1.312943,"twenty":-2.827663,"median":-2.013443,"eighty":-1.37859,"marketCap":23780755},{"date":"2024-03-15","current":-1.228539,"twenty":-2.827663,"median":-1.99684,"eighty":-1.369309,"marketCap":22251992},{"date":"2024-03-22","current":-1.819364,"twenty":-2.817793,"median":-1.988788,"eighty":-1.369309,"marketCap":32953332},{"date":"2024-03-28","current":-2.508838,"twenty":-2.81441,"median":-1.988788,"eighty":-1.373975,"marketCap":49607008},{"date":"2024-04-05","current":-2.225582,"twenty":-2.813286,"median":-2.013193,"eighty":-1.375141,"marketCap":44006217},{"date":"2024-04-12","current":-2.458256,"twenty":-2.807587,"median":-2.066589,"eighty":-1.376495,"marketCap":48606867},{"date":"2024-04-19","current":-2.040149,"twenty":-2.80618,"median":-2.065155,"eighty":-1.378239,"marketCap":40339679},{"date":"2024-04-26","current":-2.789592,"twenty":-2.80618,"median":-2.083954,"eighty":-1.37859,"marketCap":55158336},{"date":"2024-05-03","current":-3.278811,"twenty":-2.81441,"median":-2.154257,"eighty":-1.383204,"marketCap":64831627},{"date":"2024-05-10","current":-3.008179,"twenty":-2.829708,"median":-2.225173,"eighty":-1.384467,"marketCap":59480445},{"date":"2024-05-17","current":-2.706777,"twenty":-2.835307,"median":-2.225893,"eighty":-1.384495,"marketCap":64214183},{"date":"2024-05-24","current":-3.507054,"twenty":-2.863599,"median":-2.234604,"eighty":-1.387273,"marketCap":83199537},{"date":"2024-05-31","current":-4.040936,"twenty":-2.958014,"median":-2.241717,"eighty":-1.392304,"marketCap":95865084},{"date":"2024-06-07","current":-3.056015,"twenty":-2.984545,"median":-2.267774,"eighty":-1.39972,"marketCap":72499334},{"date":"2024-06-14","current":-3.488644,"twenty":-3.008452,"median":-2.292944,"eighty":-1.402924,"marketCap":82762794},{"date":"2024-06-21","current":-3.157269,"twenty":-3.016174,"median":-2.307373,"eighty":-1.403205,"marketCap":74901421},{"date":"2024-06-28","current":-3.06522,"twenty":-3.024981,"median":-2.311144,"eighty":-1.403205,"marketCap":72717706},{"date":"2024-07-05","current":-3.12045,"twenty":-3.037686,"median":-2.318701,"eighty":-1.404613,"marketCap":74027935},{"date":"2024-07-12","current":-3.516259,"twenty":-3.053559,"median":-2.33218,"eighty":-1.406806,"marketCap":83417909},{"date":"2024-07-15","current":-3.359776,"twenty":-3.057103,"median":-2.332214,"eighty":-1.406847,"marketCap":79705593},{"date":"2024-08-02","current":-2.853508,"twenty":-3.056559,"median":-2.332248,"eighty":-1.406887,"marketCap":67695161},{"date":"2024-08-09","current":-2.448494,"twenty":-3.051102,"median":-2.34235,"eighty":-1.406928,"marketCap":58086816},{"date":"2024-08-16","current":-2.426555,"twenty":-3.049827,"median":-2.33896,"eighty":-1.409608,"marketCap":68135554},{"date":"2024-08-23","current":-2.554268,"twenty":-3.042861,"median":-2.346358,"eighty":-1.412104,"marketCap":71721636},{"date":"2024-08-30","current":-2.383983,"twenty":-3.039749,"median":-2.352417,"eighty":-1.420092,"marketCap":66940193},{"date":"2024-09-06","current":-2.681981,"twenty":-3.036825,"median":-2.358441,"eighty":-1.424007,"marketCap":75307717},{"date":"2024-09-13","current":-2.767124,"twenty":-3.035105,"median":-2.377326,"eighty":-1.427844,"marketCap":77698439},{"date":"2024-09-20","current":-2.426555,"twenty":-3.030169,"median":-2.383983,"eighty":-1.429499,"marketCap":68135554},{"date":"2024-09-27","current":-2.222213,"twenty":-3.024981,"median":-2.383983,"eighty":-1.430561,"marketCap":62397823},{"date":"2024-10-04","current":-2.213699,"twenty":-3.01919,"median":-2.379637,"eighty":-1.432249,"marketCap":62158751},{"date":"2024-10-11","current":-2.247756,"twenty":-3.016174,"median":-2.371702,"eighty":-1.435374,"marketCap":63115039},{"date":"2024-10-18","current":-2.141328,"twenty":-3.012024,"median":-2.358441,"eighty":-1.437022,"marketCap":60126638},{"date":"2024-10-25","current":-2.188156,"twenty":-3.008884,"median":-2.346358,"eighty":-1.441989,"marketCap":61441534},{"date":"2024-10-31","current":-2.389927,"twenty":-3.008452,"median":-2.345739,"eighty":-1.447172,"marketCap":67107079},{"date":"2024-11-08","current":-2.83377,"twenty":-3.007134,"median":-2.34725,"eighty":-1.453828,"marketCap":79569822},{"date":"2024-11-15","current":-1.968024,"twenty":-3.002269,"median":-2.346358,"eighty":-1.460958,"marketCap":51049313},{"date":"2024-11-22","current":-2.076001,"twenty":-2.988805,"median":-2.341497,"eighty":-1.465271,"marketCap":53850185},{"date":"2024-11-29","current":-2.158258,"twenty":-2.975456,"median":-2.338036,"eighty":-1.469425,"marketCap":55983872},{"date":"2024-12-06","current":-1.933643,"twenty":-2.972266,"median":-2.332214,"eighty":-1.472826,"marketCap":50157496},{"date":"2024-12-13","current":-1.96294,"twenty":-2.967505,"median":-2.321643,"eighty":-1.479063,"marketCap":50917458},{"date":"2024-12-20","current":-1.992238,"twenty":-2.962612,"median":-2.316763,"eighty":-1.498022,"marketCap":51677420},{"date":"2024-12-27","current":-1.992238,"twenty":-2.961258,"median":-2.307373,"eighty":-1.503103,"marketCap":51677420},{"date":"2025-01-03","current":-2.041067,"twenty":-2.956932,"median":-2.307355,"eighty":-1.507276,"marketCap":52944024},{"date":"2025-01-10","current":-2.080131,"twenty":-2.941372,"median":-2.303098,"eighty":-1.515197,"marketCap":53957306},{"date":"2025-01-17","current":-1.972706,"twenty":-2.899372,"median":-2.296637,"eighty":-1.531004,"marketCap":51170779},{"date":"2025-01-24","current":-1.933643,"twenty":-2.87533,"median":-2.284723,"eighty":-1.538485,"marketCap":50157496},{"date":"2025-01-31","current":-1.875661,"twenty":-2.867606,"median":-2.264784,"eighty":-1.540033,"marketCap":48653485},{"date":"2025-02-07","current":-1.996671,"twenty":-2.860087,"median":-2.25627,"eighty":-1.544371,"marketCap":51792420},{"date":"2025-02-14","current":-1.885745,"twenty":-2.856098,"median":-2.247756,"eighty":-1.551399,"marketCap":48915063},{"date":"2025-02-21","current":-1.915998,"twenty":-2.84995,"median":-2.243914,"eighty":-1.558143,"marketCap":49699797},{"date":"2025-02-28","current":-1.986587,"twenty":-2.835718,"median":-2.237919,"eighty":-1.561594,"marketCap":51530842},{"date":"2025-03-07","current":-1.854501,"twenty":-2.835615,"median":-2.232622,"eighty":-1.563808,"marketCap":48104595},{"date":"2025-03-14","current":-1.703553,"twenty":-2.834917,"median":-2.225582,"eighty":-1.566156,"marketCap":44189105},{"date":"2025-03-21","current":-1.897628,"twenty":-2.832683,"median":-2.223693,"eighty":-1.572339,"marketCap":49223306},{"date":"2025-03-28","current":-2.073878,"twenty":-2.8282,"median":-2.216853,"eighty":-1.577368,"marketCap":48227321},{"date":"2025-04-04","current":-2.022985,"twenty":-2.827663,"median":-2.202461,"eighty":-1.578876,"marketCap":47043829},{"date":"2025-04-11","current":-1.857584,"twenty":-2.825689,"median":-2.188156,"eighty":-1.588437,"marketCap":43197478},{"date":"2025-04-17","current":-1.959369,"twenty":-2.817793,"median":-2.17779,"eighty":-1.602543,"marketCap":45564463},{"date":"2025-04-25","current":-2.671867,"twenty":-2.813564,"median":-2.188156,"eighty":-1.606359,"marketCap":62133359},{"date":"2025-05-02","current":-3.155348,"twenty":-2.827663,"median":-2.19667,"eighty":-1.631509,"marketCap":73376538},{"date":"2025-05-09","current":-2.493743,"twenty":-2.817793,"median":-2.215276,"eighty":-1.659151,"marketCap":57991135},{"date":"2025-05-16","current":-2.722426,"twenty":-2.827663,"median":-2.222213,"eighty":-1.659151,"marketCap":53643944},{"date":"2025-05-23","current":-2.753188,"twenty":-2.817793,"median":-2.225582,"eighty":-1.671207,"marketCap":54250090},{"date":"2025-05-30","current":-2.78395,"twenty":-2.815328,"median":-2.228422,"eighty":-1.673266,"marketCap":54856236},{"date":"2025-06-06","current":-2.999283,"twenty":-2.815328,"median":-2.236289,"eighty":-1.687454,"marketCap":59099260},{"date":"2025-06-13","current":-2.691665,"twenty":-2.813794,"median":-2.242361,"eighty":-1.695662,"marketCap":53037797},{"date":"2025-06-20","current":-2.768569,"twenty":-2.813356,"median":-2.24629,"eighty":-1.696859,"marketCap":54553163},{"date":"2025-06-27","current":-2.676284,"twenty":-2.813356,"median":-2.250825,"eighty":-1.698098,"marketCap":52734724},{"date":"2025-07-03","current":-2.845474,"twenty":-2.814253,"median":-2.264726,"eighty":-1.69915,"marketCap":56068529},{"date":"2025-07-11","current":-2.968522,"twenty":-2.827663,"median":-2.264784,"eighty":-1.701114,"marketCap":58493114},{"date":"2025-07-18","current":-2.737807,"twenty":-2.823715,"median":-2.284723,"eighty":-1.703553,"marketCap":53947017},{"date":"2025-07-25","current":-2.630141,"twenty":-2.816561,"median":-2.297739,"eighty":-1.703553,"marketCap":51825505},{"date":"2025-08-01","current":-2.414808,"twenty":-2.814712,"median":-2.307355,"eighty":-1.704922,"marketCap":47582481},{"date":"2025-08-08","current":-2.276379,"twenty":-2.814253,"median":-2.307364,"eighty":-1.709911,"marketCap":44854823},{"date":"2025-08-15","current":-3.182597,"twenty":-2.827663,"median":-2.314914,"eighty":-1.7146,"marketCap":51469423},{"date":"2025-08-22","current":-3.121393,"twenty":-2.83463,"median":-2.320217,"eighty":-1.715028,"marketCap":50479626},{"date":"2025-08-26","current":-3.223399,"twenty":-2.835718,"median":-2.32296,"eighty":-1.715028,"marketCap":52129287}],"updateTime":1756311123718},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAIA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562741476","title":"MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2562741476","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562741476?lang=en_us&edition=fundamental","pubTime":"2025-08-27 21:01","pubTimestamp":1756299660,"startTime":"0","endTime":"0","summary":"CHICAGO, Aug.  27, 2025  (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunothe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/27/3140098/0/en/MAIA-Biotechnology-Announces-Publication-of-Interim-Clinical-Data-on-Telomere-Targeting-Anticancer-Agent-in-Peer-Reviewed-Journal-Cells.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","BK4585","BK4107","BK4588","BK4139","LU2487616109.SGD","MAIA","L","LU0210528500.USD"],"gpt_icon":0},{"id":"2559607871","title":"MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2559607871","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559607871?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:01","pubTimestamp":1755090060,"startTime":"0","endTime":"0","summary":"Cancer-fighting immunosuppressive agents shown to disrupt telomeres and suspend growth of cancer cells CHICAGO , Aug.  13, 2025  (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/13/3132647/0/en/MAIA-Biotechnology-Granted-European-Patent-for-Next-Generation-Telomere-Targeting-Agents-for-Cancer-Therapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2487616109.SGD","BK4585","LU0053666078.USD","L","BK4107","LU0210528500.USD","MAIA","BK4588","BK4139"],"gpt_icon":0},{"id":"2558654086","title":"MAIA Biotechnology Q2 EPS $(0.18) Beats $(0.24) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2558654086","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558654086?lang=en_us&edition=fundamental","pubTime":"2025-08-11 21:48","pubTimestamp":1754920103,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.24) by 25 percent. This is a 55 percent increase over losses of $(0.40) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47030973/maia-biotechnology-q2-eps-0-18-beats-0-24-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA"],"gpt_icon":0},{"id":"2554779116","title":"FDA Grants Fast Track Designation to MAIA Biotechnology's Ateganosine for Non-Small Cell Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2554779116","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554779116?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:01","pubTimestamp":1753704080,"startTime":"0","endTime":"0","summary":"Maia Biotechnology Inc. has announced that its investigational drug, ateganosine, has received Fast Track designation from the U.S. Food and Drug Administration  for the treatment of non-small cell lung cancer . This designation is intended to expedite the development and review process for drugs that address serious conditions and meet unmet medical needs. Ateganosine, a first-in-class small molecule currently in a pivotal Phase 2 clinical trial, has shown promising results, with a median overall survival of 17.8 months in patients with prior disease progression. The Fast Track designation could potentially lead to accelerated FDA approval and priority review, positioning ateganosine to be a significant player in the NSCLC treatment market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDL6sL3hZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2554418779","title":"Maia Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2554418779","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554418779?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:01","pubTimestamp":1753704060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nTUACBT2JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2552243488","title":"MAIA Biotechnology Publishes Promising Preclinical Cancer Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2552243488","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552243488?lang=en_us&edition=fundamental","pubTime":"2025-07-18 04:33","pubTimestamp":1752784389,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. ( ($MAIA) ) just unveiled an update. On July 17, 2025, MAIA Biotechnology announced the publication of preclinical data in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-publishes-promising-preclinical-cancer-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-publishes-promising-preclinical-cancer-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2552484017","title":"MAIA Biotechnology announces publication of ateganosine prodrug data","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552484017?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:31","pubTimestamp":1752759093,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced the publication of preclinical data from its second-generation ateganosine prodrugs platform in the journal Nuc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-announces-publication-of-ateganosine-prodrug-data-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-announces-publication-of-ateganosine-prodrug-data-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2552484866","title":"MAIA Biotechnology Inc. Advances Cancer Treatment with New Clinical Study on Promising Ateganosine Prodrugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484866","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552484866?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:17","pubTimestamp":1752758235,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology Inc., a clinical-stage biopharmaceutical company, announced the publication of preclinical data for its second-generation ateganosine prodrugs in the scientific journal Nucleic Acids Research. The study, titled \"Novel Telomere-Targeting Dual-Pharmacophore Dinucleotide Prodrugs for Anticancer Therapy,\" highlights the potential of these prodrugs in enhancing cancer treatment and overcoming drug resistance. The data indicates that the compounds MAIA-2022-12 and MAIA-2021-20, when combined with an immune checkpoint inhibitor, showed improved anticancer efficacy compared to monotherapy. MAIA Biotechnology is preparing to advance at least one of these candidates into human clinical trials, pending further preclinical evaluations. No specific timeline for the clinical trials has been provided.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL2LnNSr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2550663790","title":"MAIA Biotechnology Begins Phase 2 Trial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663790","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663790?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:29","pubTimestamp":1752092954,"startTime":"0","endTime":"0","summary":"The latest announcement is out from MAIA Biotechnology, Inc. ( ($MAIA) ). On July 9, 2025, MAIA Biotechnology announced the dosing of the first pat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-begins-phase-2-trial-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-begins-phase-2-trial-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2550665365","title":"MAIA Biotechnology doses first patient in Taiwan in THIO-101 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2550665365","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550665365?lang=en_us&edition=fundamental","pubTime":"2025-07-09 21:25","pubTimestamp":1752067510,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced dosing of the first patient in Taiwan in the expansion phase of its THIO-101 Phase 2 trial for advanced non-sma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-doses-first-patient-in-taiwan-in-thio-101-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-doses-first-patient-in-taiwan-in-thio-101-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2550317658","title":"Maia Biotechnology Inc. Expands Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer with First Patient Dosed in Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2550317658","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550317658?lang=en_us&edition=fundamental","pubTime":"2025-07-09 21:15","pubTimestamp":1752066924,"startTime":"0","endTime":"0","summary":"Maia Biotechnology Inc. Expands Phase 2 Trial for Ateganosine in Advanced Non-Small Cell Lung Cancer with First Patient Dosed in Taiwan. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on July 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL5SDGD1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","LU0823434740.USD","LU0889565916.HKD","LU0053666078.USD","MAIA","LU1917777945.USD","LU0882574055.USD","LU0114720955.EUR","LU0823416689.USD","BK4585","LU2237438978.USD","LU2089984988.USD","LU1974910355.USD","LU0320765992.SGD","BK4588","BK4139","LU2023250504.SGD","LU2106854487.HKD","REGN","LU0058720904.USD","LU2362541513.USD","LU0823434583.USD","LU2468319806.SGD","LU0289739699.SGD","LU2362541273.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2548001737","title":"MAIA Biotechnology Unveils Promising Telomere-Targeting Agents for Cancer at Upcoming FEBS 2025 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2548001737","media":"Reuters","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548001737?lang=en_us&edition=fundamental","pubTime":"2025-07-01 21:01","pubTimestamp":1751374861,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc., a clinical-stage biopharmaceutical company, has announced upcoming presentations at the 49th Federation of European Biochemical Societies  2025 Congress in Istanbul, Turkey. The company will present two posters focusing on their lead telomere-targeting agents and next-generation cancer treatments. The first presentation, to be delivered by Z. Günnur Dikmen, M.D., Ph.D., is titled \"Telomere-targeting therapeutics RiboTHIO and THIO synergize with radiotherapy and immune checkpoint blockade to suppress lung tumor growth.\" The second presentation, by Gamze Tuna, is titled \"The effects of telomerase mediated telomere-targeting novel drug candidate compounds on oxidative DNA damage and DNA repair on A549 cells.\" Both presentations are scheduled for July 7, 2025, during the Cancer Therapy session. The abstracts will be accessible in the FEBS Open Bio Journal post-Congress.Disclaimer: This news brief was created by Public Technologies  using generative artificial inte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL441ngB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2546789800","title":"Maia Biotechnology Signs Stock Purchase Agreement with Prevail Partners for Phase 3 Cancer Study Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2546789800","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546789800?lang=en_us&edition=fundamental","pubTime":"2025-06-26 18:02","pubTimestamp":1750932149,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. has entered into a significant stock purchase agreement with Prevail Partners, LLC, involving the issuance and sale of $587,905 worth of its common stock. The agreement, signed on June 24, 2025, includes an upfront payment of $58,800.3333 in shares and 36 equal tranche payments of $14,697.333 each. The stock will be sold at a minimum share price of $1.74, with a maximum issuance of 337,876 shares, adhering to a 19.99% issuance cap. The proceeds from this agreement will be used to fund technologies and services provided by Prevail Infoworks under a previously established Master Service and Technology Agreement. These services are crucial for a Phase 3 study evaluating THIO in combination with cemiplimab versus chemotherapy for advanced non-small cell lung cancer treatment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL2yMKvd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2545331862","title":"MAIA Biotechnology Appoints Oncologists to Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2545331862","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545331862?lang=en_us&edition=fundamental","pubTime":"2025-06-24 21:46","pubTimestamp":1750772794,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. ( ($MAIA) ) has provided an update. On June 24, 2025, MAIA Biotechnology announced the appointment of two leading oncologi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-appoints-oncologists-to-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-appoints-oncologists-to-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2545528294","title":"BRIEF-MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2545528294","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545528294?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:20","pubTimestamp":1750767618,"startTime":"0","endTime":"0","summary":"BRIEF-MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory BoardJune 24 (Reuters) - Maia Biotechnology Inc MAIA.A:MAIA BIOTECHNOLOGY WELCOMES LEADIN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUA3W6SQV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2545282521","title":"MAIA Biotechnology Inc. Appoints Leading Oncologists Claudia Fulgenzi and David Pinato to Scientific Advisory Board for Upcoming HCC Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2545282521","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545282521?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:15","pubTimestamp":1750767329,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology Inc. Appoints Leading Oncologists Claudia Fulgenzi and David Pinato to Scientific Advisory Board for Upcoming HCC Clinical Trials. Maia Biotechnology Inc. has announced changes to its management team with the appointment of two prominent oncologists, Claudia Fulgenzi, MD, and David J. Pinato, MD, PhD, to its Scientific Advisory Board. Both experts will provide guidance on the design and protocols for Maia's upcoming clinical trial in hepatocellular carcinoma, focusing on the company's lead candidate ateganosine  combined with a checkpoint inhibitor. This development is part of Maia's ongoing efforts in targeted immunotherapies for cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. publishe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL17JRfB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2544542900","title":"Sector Update: Health Care Stocks Softer Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2544542900","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544542900?lang=en_us&edition=fundamental","pubTime":"2025-06-19 03:49","pubTimestamp":1750276154,"startTime":"0","endTime":"0","summary":"Health care stocks were decreasing late Wednesday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund  easing 0.1%.The iShares Biotechnology ETF  rose 0.4%.In sector news, US Secretary of Health and Human Services Robert Kennedy Jr. is weighing a proposal for a key government vaccine advisory panel to scrutinize vaccines with aluminum ingredients, Bloomberg reported. A review could impact at least two dozen vaccines, the report said.In corporate news, Zoetis  shares were falling 3.7% after Stifel downgraded the stock to hold from buy and cut its price target to $160 from $165.Gilead Sciences  shares added 0.3% after the drugmaker said the US Food and Drug Administration has approved its Yeztugo, its twice-yearly injectable for HIV prevention.Caris Life Sciences  shares surged 23% in their Nasdaq debut Wednesday after the company priced its IPO of 23.5 million shares at $21 each.Grail  shares jumped 13% after the firm said it has seen better ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B7SZLL34.SGD","LU1066053197.SGD","BK4585","LU0823416689.USD","LU0320765992.SGD","LU1066051498.USD","BK4588","LU1674673428.USD","BK4139","MAIA","IBB","BK7104","BK4581","IE00B19Z9505.USD","BK4104","IE00B3T34201.USD","LU0058720904.USD","LU2087621335.USD","CAI.AU","CAI","ZTS","GRAL","LU2360106947.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU2028103732.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","LU2023251221.USD","GILD","BK4568","LU1585245621.USD","LU0471298777.SGD","LU2089283258.USD","LU1571399168.USD","LU2089984988.USD","LU2308191902.HKD","BK4007","BK4550","BK4532","LU0158827948.USD","XLV","IE0002270589.USD","LU0889565916.HKD","LU1941712348.USD","LU0471298694.HKD","LU0345774631.USD","LU2271345857.HKD","LU0385154629.USD"],"gpt_icon":0},{"id":"2544970151","title":"Maia Biotechnology Inc. Announces New Clinical Study Agreement with Roche for Cancer Treatment Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2544970151","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544970151?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:15","pubTimestamp":1750252513,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology Inc. has announced a new clinical master supply agreement with Roche to support future studies on the combination of MAIA's telomere-targeting agent, ateganosine , and Roche's checkpoint inhibitor, atezolizumab . The studies will investigate the treatment's efficacy and safety for multiple hard-to-treat cancers. The agreement follows preclinical findings showing that ateganosine is highly synergistic with atezolizumab. The results of these studies have not yet been presented and are anticipated in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on June 18, 2025, and is solely responsible for the infor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL4sS8Fq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2544184239","title":"MAIA Biotechnology Enters Inducement Offer Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2544184239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544184239?lang=en_us&edition=fundamental","pubTime":"2025-06-18 04:29","pubTimestamp":1750192178,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc. ( ($MAIA) ) just unveiled an update. On June 17, 2025, MAIA Biotechnology, Inc. entered into inducement offer letter agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-enters-inducement-offer-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maia-biotechnology-enters-inducement-offer-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2544990737","title":"Maia Biotechnology Inc. Announces Warrant Exercise Agreements for 219,283 Shares at Reduced Price of $1.50, Securing $328,925 in Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2544990737","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544990737?lang=en_us&edition=fundamental","pubTime":"2025-06-18 04:11","pubTimestamp":1750191062,"startTime":"0","endTime":"0","summary":"Maia Biotechnology Inc. Announces Warrant Exercise Agreements for 219,283 Shares at Reduced Price of $1.50, Securing $328,925 in Gross Proceeds. Maia Biotechnology Inc. has entered into inducement offer letter agreements with various accredited investors, collectively referred to as the Participating Holders. These agreements involve the exercise of warrants to purchase a total of 219,283 shares of common stock at a reduced exercise price of $1.50 per share. The transactions, which are expected to close around June 18, 2025, will generate approximately $328,925 in gross proceeds for the company, intended for general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maia Biotechnology Inc. published the original content","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL11gxz9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}]}}